Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Neuland Laboratories Limited (NEULANDLAB.BO) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Wockhardt Limited, Wockhardt Limited, AstraZeneca Pharma India Limited, AstraZeneca Pharma India Limited, ERIS.BO, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| WOCKPHARMA.BO | Wockhardt Limited | $315.8B |
| WOCKPHARMA.NS | Wockhardt Limited | $315.6B |
| ASTRAZEN.NS | AstraZeneca Pharma India Limited | $205.6B |
| ASTRAZEN.BO | AstraZeneca Pharma India Limited | $203.9B |
| ERIS.BO | ERIS.BO | — |
| ERIS.NS | ERIS.NS | — |
| JUBLPHARMA.BO | JUBLPHARMA.BO | — |
| PEL.NS | PEL.NS | — |
| JUBLPHARMA.NS | JUBLPHARMA.NS | — |
| APLLTD.NS | APLLTD.NS | — |